Noncirrhotic portal hypertension.

[1]  Y. Bayraktar,et al.  Experience of a single center with congenital hepatic fibrosis: a review of the literature. , 2010, World journal of gastroenterology.

[2]  B. Vennervald,et al.  Schistosomiasis and Other Trematode Infections , 2009 .

[3]  Amitesh Pathak,et al.  Intracholedochal varices in portal hypertensive biliopathy , 2009 .

[4]  Y. Chawla,et al.  Review article: the modern management of portal vein thrombosis , 2009, Alimentary pharmacology & therapeutics.

[5]  V. Taneja,et al.  Possible HLA influence in governing susceptibility to non-cirrhotic portal fibrosis. , 2008, Tissue antigens.

[6]  M. Sugiura,et al.  Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study. , 2008, Liver.

[7]  P. Hsu,et al.  Nodular regenerative hyperplasia of the liver. , 2008, Journal of the Chinese Medical Association : JCMA.

[8]  J. Bosch,et al.  Portal hypertension and its complications. , 2008, Gastroenterology.

[9]  Y. Chawla,et al.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment , 2007, Hepatology international.

[10]  E. Cholongitas,et al.  Veno occlusive disease: update on clinical management. , 2007, World journal of gastroenterology.

[11]  N. Nagasue,et al.  Experimental investigation of the role of endothelin‐1 in idiopathic portal hypertension , 2007, Journal of gastroenterology and hepatology.

[12]  A. Tamori,et al.  Expression of Connective Tissue Growth Factor in the Human Liver with Idiopathic Portal Hypertension , 2007, Molecular medicine.

[13]  D. Valla,et al.  [3] A PROSPECTIVE FOLLOW-UP STUDY ON 163 PATIENTS WITH BUDD-CHIARI SYNDROME: RESULTS FROM THE EUROPEAN NETWORK FOR VASCULAR DISORDERS OF THE LIVER (EN-VIE) , 2007 .

[14]  Y. Chawla,et al.  Portal hypertensive biliopathy , 2006, Gut.

[15]  S. Sarin,et al.  Surgical guidelines for the management of extra‐hepatic portal vein obstruction , 2006, Pediatric transplantation.

[16]  S. Sarin,et al.  Noncirrhotic portal hypertension. , 2006, Clinics in liver disease.

[17]  A. Helmy.  Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome , 2006, Alimentary pharmacology & therapeutics.

[18]  H. Saisho,et al.  Study of portal vein thrombosis in patients with idiopathic portal hypertension in Japan , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[19]  B. Thapa,et al.  Band Ligation Plus Sclerotherapy Versus Sclerotherapy Alone in Children With Extrahepatic Portal Venous Obstruction , 2005, Journal of clinical gastroenterology.

[20]  P. Thuluvath,et al.  The Utility of TIPS in the Management of Budd-Chiari Syndrome , 2005, Annals of surgery.

[21]  A. Santra,et al.  Implications of oxidative stress and hepatic cytokine (TNF-alpha and IL-6) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity. , 2005, Toxicology and applied pharmacology.

[22]  P. Mannucci,et al.  Risk factors for thrombophilia in extrahepatic portal vein obstruction , 2005, Hepatology.

[23]  Z. Ben‐Ari.  Ascites after transplantation—A mystery , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[24]  Giuseppe Brancatelli,et al.  Congenital hepatic fibrosis: CT findings in 18 adults. , 2004, Radiology.

[25]  D. Valla,et al.  Clinicopathological forms and prognostic index in Budd-Chiari syndrome. , 2003, Journal of hepatology.

[26]  K. Yamao,et al.  Acute portal vein thrombosis after EUS-guided FNA of pancreatic cancer: case report. , 2003, Gastrointestinal endoscopy.

[27]  N. Soper,et al.  Portal vein thrombosis after splenectomy. , 2002, American journal of surgery.

[28]  K. Okuda.  Non‐cirrhotic portal hypertension versus idiopathic portal hypertension , 2002, Journal of gastroenterology and hepatology.

[29]  T. R. Sharma,et al.  Endoscopic Sclerotherapy of Gastric Variceal Bleeding with N-Butyl-2-Cyanoacrylate , 2002, Journal of clinical gastroenterology.

[30]  D. Valla,et al.  Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients , 2002, Gut.

[31]  N. Lassau,et al.  Prognostic value of doppler-ultrasonography in hepatic veno-occlusive disease: A Study of 71 Children , 2002, Transplantation.

[32]  A. Tamori,et al.  Portal vein thrombosis following percutaneous ethanol injection therapy for hepatocellular carcinoma. , 2002, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[33]  M. Orloff,et al.  Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years' experience with portal-systemic shunt. , 2002, Journal of the American College of Surgeons.

[34]  D. Kapoor,et al.  Non‐cirrhotic portal fibrosis: Current concepts and management , 2002, Journal of gastroenterology and hepatology.

[35]  S. Sarin,et al.  A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices , 2002, American Journal of Gastroenterology.

[36]  G. McDonald,et al.  Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). , 2002, Seminars in liver disease.

[37]  D. Valla.  Hepatic Vein Thrombosis (Budd-Chiari Syndrome) , 2002, Seminars in liver disease.

[38]  M. Okudaira,et al.  Idiopathic portal hypertension and its pathology. , 2002, Seminars in liver disease.

[39]  Y. Chawla,et al.  Non‐cirrhotic portal fibrosis (idiopathic portal hypertension): Experience with 151 patients and a review of the literature , 2002, Journal of gastroenterology and hepatology.

[40]  D. L. Freeman,et al.  Harrison's Principles of Internal Medicine , 2001 .

[41]  S. Sarin,et al.  Coagulation profile and platelet function in patients with extrahepatic portal vein obstruction and non‐cirrhotic portal fibrosis , 2001, Journal of gastroenterology and hepatology.

[42]  R. Aggarwal,et al.  Functional protein C and anti-cardiolipin antibody in children with portal vein thrombosis. , 2001, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[43]  F R Rosendaal,et al.  Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. , 2000, Blood.

[44]  J. Thompson,et al.  Portosystemic shunting in children during the era of endoscopic therapy: improved postoperative growth parameters. , 2000, Journal of pediatric gastroenterology and nutrition.

[45]  M. Heikinheimo,et al.  Serum tumor marker CA 125 is an early and sensitive indicator of veno-occlusive disease in children undergoing bone marrow transplantation. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[46]  E. Guinan,et al.  THE PATHOLOGY, DIAGNOSIS, AND TREATMENT OF HEPATIC VENO‐OCCLUSIVE DISEASE: CURRENT STATUS AND NOVEL APPROACHES , 1999, British journal of haematology.

[47]  Y. Chawla,et al.  Biliary changes in extrahepatic portal venous obstruction: compression by collaterals or ischemic? , 1999, Gastrointestinal endoscopy.

[48]  D. Samuel,et al.  “Silent” presentation of veno‐occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection , 1999, Hepatology.

[49]  A. Santra,et al.  Hepatic manifestations in chronic arsenic toxicity. , 1999, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[50]  R. Sackstein,et al.  Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation , 1999, Bone Marrow Transplantation.

[51]  L. Abel,et al.  Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. , 1999, American journal of human genetics.

[52]  T. Fukuda,et al.  Interventional radiologic treatment for idiopathic portal hypertension , 1999, CardioVascular and Interventional Radiology.

[53]  B. Fowler,et al.  Arsenic: health effects, mechanisms of actions, and research issues. , 1999, Environmental health perspectives.

[54]  K. Tokushige,et al.  Analysis of adhesion molecules in patients with idiopathic portal hypertension , 1999, Journal of gastroenterology and hepatology.

[55]  R. Sinha.  Grayscale and pulsed Doppler characteristics of non-cirrhotic portal fibrosis: a preliminary report. , 1999, Clinical radiology.

[56]  A. Gratwohl,et al.  Incidence and Outcome of Hepatic Veno-Occlusive Disease After Blood or Marrow Transplantation: A Prospective Cohort Study of the European Group for Blood and Marrow Transplantation , 1998 .

[57]  R. Makuch,et al.  Portal hypertension and variceal bleeding: An AASLD single topic symposium , 1998, Hepatology.

[58]  C. Turner,et al.  Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection. , 1998, The Journal of infectious diseases.

[59]  G. Temučin,et al.  Sonographic findings in noncirrhotic portal fibrosis , 1998, Journal of clinical ultrasound : JCU.

[60]  P. Dabadghao,et al.  Extrahepatic portal vein obstruction in children: anthropometry, growth hormone, and insulin-like growth factor I. , 1997, Journal of pediatric gastroenterology and nutrition.

[61]  A. Dinda,et al.  Increased incidence of glomerulonephritis following spleno-renal shunt surgery in non-cirrhotic portal fibrosis. , 1997, Kidney international.

[62]  Rp Singh,et al.  Effect of shunt surgery on spleen size, portal pressure and oesophageal varices in patients with non‐cirrhotic portal hypertension , 1997, Journal of gastroenterology and hepatology.

[63]  J. Dilawari,et al.  Sclerotherapy in Noncirrhotic Portal Fibrosis , 1997, Digestive Diseases and Sciences.

[64]  S. Sarin,et al.  Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence. , 1997, Journal of hepatology.

[65]  J. Herrero,et al.  Interventional therapeutic techniques in Budd-Chiari syndrome , 1997, CardioVascular and Interventional Radiology.

[66]  N. Levitt,et al.  Autonomic neuropathy in extra-hepatic portal vein thrombosis: evidence for impaired autonomic reflex arc. , 1997, Journal of hepatology.

[67]  J. Olin,et al.  Thrombolysis for acute Budd-Chiari syndrome: case report and literature review. , 1996, The American journal of gastroenterology.

[68]  K. Ishak,et al.  Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship. , 1996, The American journal of gastroenterology.

[69]  M. Gebel,et al.  Which is the best surgery for budd‐chiari syndrome: Venous decompression or liver transplantation? a single‐center experience with 50 patients , 1995, Hepatology.

[70]  T. Kofler,et al.  Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. , 1995, Transplantation.

[71]  V. Vilgrain,et al.  The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. , 1994, Gastroenterology.

[72]  Y. Chawla,et al.  Hepatic Outflow Obstruction (Budd‐Chiari Syndrome) Experience with 177 Patients and a Review of the Literature , 1994, Medicine.

[73]  G. Anderson,et al.  Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  Y. Nakanuma,et al.  Non-specific immunological abnormalities and association of autoimmune diseases in idiopathic portal hypertension. A study by questionnaire. , 1993, Hepato-gastroenterology.

[75]  Y. Chawla,et al.  Side-to-side lienorenal shunt without splenectomy in noncirrhotic portal hypertension in children. , 1993, Journal of pediatric surgery.

[76]  N. Mcintyre,et al.  Adult “idiopathic” extrahepatic venous thrombosis , 1992, Digestive Diseases and Sciences.

[77]  D. Bhargava,et al.  Efficacy of endoscopic sclerotherapy on long‐term management of oesophageal varices: A comparative study of results in patients with cirrhosis of the liver, non‐cirrhotic portal fibrosis (NCPF) and extrahepatic portal venous obstruction (EHO) * , 1991, Journal of gastroenterology and hepatology.

[78]  M. Goenka,et al.  Outcome of injection sclerotherapy using absolute alcohol in patients with cirrhosis, non-cirrhotic portal fibrosis, and extrahepatic portal venous obstruction. , 1991, Gastrointestinal endoscopy.

[79]  A. Geubel,et al.  Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. , 1991, Gastroenterology.

[80]  Y. Chawla,et al.  Anorectal varices--their frequency in cirrhotic and non-cirrhotic portal hypertension. , 1991, Gut.

[81]  P. Sahni,et al.  Extrahepatic portal vein obstruction , 1990, The British journal of surgery.

[82]  S. Sarin,et al.  Immunological profile of patients with non‐cirrhotic portal fibrosis , 1990, Journal of gastroenterology and hepatology.

[83]  K. Abu-Elmagd,et al.  Selective Shunt Versus Nonshunt Surgery for Management of Both Schistosomal and Nonschistosomal Variceal Bleeders , 1990, Annals of surgery.

[84]  I. Wanless.  micronodular transpormation (nodular regenerative hyperplasia) of the liver: A report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules , 1990, Hepatology.

[85]  K. Sugimachi,et al.  Pathology of the Liver in “Idiopathic Portal Hypertension” Associated with Autoimmune Disease , 1989, Acta pathologica japonica.

[86]  C. Kiire.  Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis. , 1989, BMJ.

[87]  S. Sarin.  Non-cirrhotic portal fibrosis. , 1989, Journal of gastroenterology and hepatology.

[88]  W. Millikan,et al.  Management of Variceal Bleeding in Patients with Noncirrhotic Portal Vein Thrombosis , 1988, Annals of surgery.

[89]  M. Omata,et al.  Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits. , 1988, Gastroenterology.

[90]  C. Babbs,et al.  Non-cirrhotic portal hypertension with hypoxaemia. , 1988, Gut.

[91]  L. Grochow,et al.  VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION , 1987, Transplantation.

[92]  R. Gibson,et al.  Comparison of ultrasonography, computed tomography and 99mTc liver scan in diagnosis of Budd-Chiari syndrome. , 1987, Gut.

[93]  J. Fermanian,et al.  A Randomized Trial for the Study of the Elective Surgical Treatment of Portal Hypertension in Mansonic Schistosomiasis , 1986, Annals of surgery.

[94]  K. D. de Cock.  Hepatosplenic schistosomiasis: a clinical review. , 1986, Gut.

[95]  G. Birken,et al.  Extrahepatic portal hypertension in children. Long-term evaluation. , 1986, American journal of surgery.

[96]  J. Barnard,et al.  Noncirrhotic portal fibrosis after Wilms' tumor therapy. , 1986, Gastroenterology.

[97]  M. Kage,et al.  PORTAL VEIN OR HEPATIC VEIN ? , 1985 .

[98]  P. Stuiver.  Acute schistosomiasis (Katayama fever). , 1984, British medical journal.

[99]  D. Levison,et al.  Slow cirrhosis—or no cirrhosis? A lesion causing benign intrahepatic portal hypertension , 1982, The Journal of pathology.

[100]  E. Walter,et al.  NON-CIRRHOTIC PORTAL HYPERTENSION , 1981, The Lancet.

[101]  D. Levison,et al.  Non-cirrhotic intrahepatic portal hypertension: A long term follow-up study. , 1981, The Quarterly journal of medicine.

[102]  M. Hales,et al.  Nodular regenerative hyperplasia of the liver: report of two cases and review of the literature. , 1981, Journal of clinical gastroenterology.

[103]  T. Godwin,et al.  Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis. , 1980, Medicine.

[104]  T. Godwin,et al.  Nodular Regenerative Hyperplasia of the Liver in Hematologic Disorders: A Possible Response to Obliterative Portal Venopathy , 1980 .

[105]  A. Qizilbash,et al.  Nodular regenerative hyperplasia of the liver: diagnosis by liver biopsy. , 1980, Canadian Medical Association journal.

[106]  S. Sherlock,et al.  The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. , 1979, The Quarterly journal of medicine.

[107]  F. Schaffner.  Non-cirrhotic portal fibrosis with portal hypertension , 1979 .

[108]  P. N. Chhuttani,et al.  The pathology of noncirrhotic portal fibrosis: a review of 32 autopsy cases. , 1979, Human pathology.

[109]  P. Rougier,et al.  Nodular regenerative hyperplasia of the liver. Report of six cases and review of the literature. , 1978, Gastroenterology.

[110]  P. Rougier,et al.  Nodular regenerative hyperplasia of the liver. Report of six cases and review of the literature. , 1978, Gastroenterology.

[111]  D. Kerr,et al.  Congenital hepatic fibrosis: the long-term prognosis. , 1978, Gut.

[112]  J. Pimentel,et al.  Pulmonary and hepatic granulomatous disorders due to the inhalation of cement and mica dusts. , 1978 .

[113]  J. Pimentel,et al.  Liver disease in vineyard sprayers. , 1977, Gastroenterology.

[114]  J. Cǒté,et al.  Noncirrhotic presinusoidal portal hypertension associated with chronic arsenical intoxication. , 1975, Gastroenterology.

[115]  H. Falk,et al.  Vinyl-chloride-induced liver disease. From idiopathic portal hypertension (Banti's syndrome) to Angiosarcomas. , 1975, The New England journal of medicine.

[116]  J. Ludwig,et al.  Liver injury associated with methotrexate therapy for psoriasis. , 1973, Mayo Clinic proceedings.

[117]  S. Bhargava,et al.  Noncirrhotic portal fibrosis. , 1971, The American journal of medicine.

[118]  A. Cheever,et al.  Alterations of the intrahepatic vasculature in hepatosplenic schistosomiasis mansoni. , 1971, The American journal of tropical medicine and hygiene.

[119]  N. Nayak,et al.  Ultrastructure of the liver in non-cirrhotic portal fibrosis with portal hypertension , 1970, Gut.

[120]  A. Coutinho.  Hemodynamic studies of portal hypertension in schistosomiasis. , 1968, The American journal of medicine.

[121]  J. Boyer,et al.  Non-cirrhotic portal fibrosis with portal hypertension: a new syndrome. I. Clinical and function studies and results of operations. , 1967, The Indian journal of medical research.

[122]  T. Reynolds,et al.  Extra- and Intrahepatic Portal Hypertension without Cirrhosis (Hepatoportal Sclerosis) , 1965, Annals of surgery.

[123]  J. Dušek,et al.  NEEDLE BIOPSY OF THE LIVER IN SCHISTOSOMIASIS MANSONI: THE VALUE OF HISTOLOGICAL EXAMINATION. , 1965, The Journal of tropical medicine and hygiene.

[124]  Tizard Jp.  Portal hypertension following exchange transfusion through the umbilical vein. , 1962 .

[125]  A. Cohen,et al.  Idiopathic presinusoidal portal hypertension (Banti's syndrome). , 1962, Annals of internal medicine.

[126]  Z. Andrade,et al.  Hepatic changes in advanced schistosomiasis. , 1962, Gastroenterology.

[127]  S. Shaldon,et al.  Obstruction to the extrahepatic portal system in childhood. , 1962, Lancet.

[128]  G. Hallenbeck,et al.  Esophagogastric varices without hepatic cirrhosis. A clinical study of treatment for their bleeding in 72 cases. , 1961, Archives of surgery.

[129]  D. Jelliffe,et al.  Veno-occlusive disease of liver with nonportal type of cirrhosis, occurring in Jamaica. , 1954, A.M.A. archives of pathology.

[130]  Glennis M Andall.  Report of the Ministry of Health , 1951 .

[131]  P. Ravenna.  BANTI SYNDROME (FIBROCONGESTIVE SPLENOMEGALY): DEFINITION, CLASSIFICATION AND PATHOGENESIS , 1940 .

[132]  H. Janssen,et al.  Vascular liver disorders (I): diagnosis, treatment and prognosis of Budd-Chiari syndrome. , 2008, The Netherlands journal of medicine.

[133]  Okan Akhan,et al.  Imaging findings in congenital hepatic fibrosis. , 2007, European journal of radiology.

[134]  Hepatosplenic schistosomiasis: a clinical review , 2006 .

[135]  Z. Andrade.  Schistosomal hepatopathy. , 2004, Memorias do Instituto Oswaldo Cruz.

[136]  M. Ishii,et al.  Idiopathic portal hypertension in a systemic sclerosis patient heterozygous for factor V Leiden mutation , 2002, Rheumatology International.

[137]  A. Ferrari,et al.  the Harwood Academic Publishers imprint, part of The Gordon and Breach Publishing Group. Printed in India. Band Ligation or Sclerotherapy as Endoscopic Treatment for Oesophageal Varices in Schistosomotic Patients " Results of a Randomized Study , 1997 .

[138]  D. Harron,et al.  Propranolol reduces mortality in patients with portal hypertension secondary to schistosomiasis. , 1994, Annals of tropical medicine and parasitology.

[139]  A. Naber,et al.  Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. , 1991, Journal of hepatology.

[140]  J. Ludwig,et al.  Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. , 1990, Mayo Clinic proceedings.

[141]  S. Nundy,et al.  Glomerulonephritis complicating non-cirrhotic portal fibrosis. , 1989, Journal of gastroenterology and hepatology.

[142]  M. Kage,et al.  Portal vein or hepatic vein? A curious aberrant vasculature in the liver with idiopathic portal hypertension. , 1985, Acta pathologica japonica.

[143]  K. D. Cock.  Human schistosomiasis and its management , 1984 .

[144]  K. D. de Cock.  Human schistosomiasis and its management. , 1984, The Journal of infection.

[145]  K. Ishak,et al.  Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. , 1981, Human pathology.

[146]  R. Carruthers,et al.  Bilharzial portal fibrosis: an important cause of portal hypertension. , 1978, Annals of the Royal College of Surgeons of England.

[147]  J. Boyer,et al.  Idiopathic portal hypertension. Comparison with the portal hypertension of cirrhosis and extrahepatic portal vein obstruction. , 1967 .

[148]  J. Tizard.  Portal hypertension following exchange transfusion through the umbilical vein. , 1962, Proceedings of the Royal Society of Medicine.